Forensic Science International
Volume 159, Issue 2 , Pages 104-112 , 2 June 2006

Validation of the Cozart® Amphetamine Microplate EIA for the analysis of amphetamines in oral fluid

  • Gail Cooper

      Affiliations

    • Cozart plc, Abingdon, Oxfordshire, UK
    • ,
  • Lisa Wilson

      Affiliations

    • Cozart plc, Abingdon, Oxfordshire, UK
    • ,
  • Claire Reid

      Affiliations

    • Cozart plc, Abingdon, Oxfordshire, UK
    • ,
  • Chris Hand

      Affiliations

    • Cozart plc, Abingdon, Oxfordshire, UK
    • ,
  • Vina Spiehler

      Affiliations

    • Spiehler and Associates, Forensic Toxicology, 422 Tustin Avenue, Newport Beach, CA 92663, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 949 642 0574; fax: +1 949 642 2852.

Received 15 April 2005 ,Revised 29 June 2005 ,Accepted 30 June 2005.

References 

  1. Wan SH, Matin SB, Azarnoff DL. Kinetics, salivary excretion of amphetamine isomers and effect of urinary pH. Clin. Pharmacol. Ther. 1978;23:585–590
  2. Matin SB, Wan SH, Knight JB. Quantitative determination of enantiomeric compounds: simultaneous measurement of the optical isomers of amphetamine in human plasma and saliva using chemical ionization mass spectrometry. Biomed. Mass Spectrom. 1977;4(2):118–121
  3. Vapaatalo H, Karkkainen S, Senius KE. Comparison of saliva and urine samples in thin-layer chromatographic detection of central nervous stimulants. Int. J. Clin. Pharm. Res. 1984;4:5–8
  4. De la Torre R, Farre M, Navarro M, Pacifici R, Zuccaro P, Pichini S. Clinical pharmacokinetics of amfetamine and related substances: monitoring in conventional and non-conventional matrices. Clin. Pharmacokinet. 2004;43:157–185
  5. Suzuki S, Inoue T, Hori V, Inayama S. Analysis of methamphetamine in hair, nail, sweat and saliva by mass fragmentography. J. Anal. Toxicol. 1989;13:176–178
  6. Schepers RJ, Oyler JM, Joseph RE, Cone JE, Moolchan ET, Huestis MA. Methamphetamine and amphetamine pharmacokinetics in oral fluid and plasma after controlled oral methamphetamine administration to human volunteers. Clin. Chem. 2003;49:121–132
  7. Kintz P. Excretion of MBDB and BDB in urine, saliva and sweat following single oral administration. J. Anal. Toxicol. 1997;21:570–575
  8. Kintz P, Samyn N. Determination of “Ecstasy” components in alternative biologic specimens. J. Chromatogr. B. 1999;7333:137–143
  9. Navarro M, Pichini S, Farre M, et al. Usefulness of saliva for measurement of 3,4-methylenedioxymethamphetamine and its metabolites: correlation with plasma drug concentrations and effect of salivary pH. Clin. Chem. 2001;47:1788–1795
  10. Samyn N, DeBoeck G, Wood M, Lamers CT, DeWaard D, Brookhuis KA, et al. Plasma, oral fluid and sweat wipe ecstasy concentrations in controlled and real life conditions. Forensic Sci. Int. 2002;128:90–97
  11. Fendrich M, Johnson T, Hubbell A, Wislar J, Spiehler V. The utility of drug testing in epidemiological research: results from an ACASI general population survey. Addiction. 2004;99:197–208
  12. Amphetamine Microplate EIA Oral Fluid Application, M110R1. Cozart Bioscience Ltd.; 2003;
  13. Cooper GA, Allen DL, Scott KS, Oliver JS, Dittion J, Smith ID. Hair analysis: self-reported use of “speed” and “ecstasy” compared with laboratory findings. J. Forensic Sci. 2000;45(2):400–406

PII: S0379-0738(05)00396-8

doi: 10.1016/j.forsciint.2005.06.011

Forensic Science International
Volume 159, Issue 2 , Pages 104-112 , 2 June 2006

Article Tools

* Image Usage & Resolution